T. Rowe Price Investment Management, Inc. Haemonetics Corp Transaction History
T. Rowe Price Investment Management, Inc.
- $162 Billion
- Q4 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 2,553,814 shares of HAE stock, worth $151 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
2,553,814
Previous 2,850,637
10.41%
Holding current value
$151 Million
Previous $229 Million
12.98%
% of portfolio
0.12%
Previous 0.14%
Shares
6 transactions
Others Institutions Holding HAE
# of Institutions
344Shares Held
52.2MCall Options Held
600KPut Options Held
474K-
Black Rock Inc. New York, NY5.96MShares$352 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.18MShares$306 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.42MShares$261 Million0.29% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.24MShares$251 Million0.07% of portfolio
-
State Street Corp Boston, MA1.95MShares$115 Million0.01% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.04B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...